Suppr超能文献

结节性硬化症患者巨大有症状血管平滑肌脂肪瘤的保守治疗

Conservative management of giant symptomatic angiomyolipomas in patients with the tuberous sclerosis complex.

作者信息

Danforth Teresa L, Lane Brian R, Novick Andrew C

机构信息

Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio, USA.

出版信息

BJU Int. 2007 Oct;100(4):794-7. doi: 10.1111/j.1464-410X.2007.07059.x. Epub 2007 Jun 21.

Abstract

OBJECTIVE

To present two patients with the tuberous sclerosis complex in whom giant angiomyolipomas (AMLs) were managed conservatively for >20 years, as large (>4 cm) symptomatic AMLs are generally treated with embolization or nephrectomy because of the risks of haemorrhage.

PATIENTS AND METHODS

The first patient initially presented with bilateral renal AMLs replacing >70% of his parenchymal volume, and a large left renal cyst. Since presentation he was hospitalized three times, but has had no transfusions or procedures to treat his AMLs. His renal function has remained stable during this 21-year interval. The second patient initially presented with bilateral renal AMLs that were not amenable to nephron-sparing surgery. After removing her nonfunctioning left kidney, the 24-cm AML in her right kidney was managed conservatively for >20 years, during which she had 44 transfusions and 11 hospitalizations before uncomplicated right nephrectomy and subsequent need for haemodialysis.

CONCLUSION

Conservative management of AMLs can preserve renal function for >20 years in patients with tuberous sclerosis at high risk of end-stage renal disease.

摘要

目的

报告两例结节性硬化症患者,其巨大血管平滑肌脂肪瘤(AML)保守治疗超过20年,因为有出血风险,通常对有症状的大(>4cm)AML采用栓塞或肾切除术治疗。

患者和方法

首例患者最初表现为双侧肾AML替代了超过70%的肾实质体积,以及一个大的左肾囊肿。自发病以来,他住院三次,但未接受输血或治疗其AML的手术。在这21年期间,他的肾功能一直保持稳定。第二例患者最初表现为双侧肾AML,无法进行保留肾单位手术。切除其无功能的左肾后,对其右肾中24cm的AML保守治疗超过20年,在此期间,她输血44次,住院11次,之后进行了无并发症的右肾切除术,随后需要进行血液透析。

结论

对于有终末期肾病高风险的结节性硬化症患者,AML的保守治疗可使肾功能维持超过20年。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验